119532-26-2Cl.Clc1cccc(N2CCNCC2)c1ClCYQFNNSFAGXCEC-UHFFFAOYSA-N119532-26-2DTXSID50866037Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 1.5% (1 of 67) of reports.
Warning
H302 (13.4%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 67 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Warning
UsesThis product is intended for forensic and research purposes and it is an aripiprazole intermediate.
UsesAripiprazole (A771000) intermediate.
Preparationβ,β'-dichlorodiethylamine hydrochloride was synthesized by chlorination under solvent-free conditions using diethanolamine as the starting material. Then, it was cyclized with 2,3-dichlorophenylpiperazine in water to give 1-(2,3-dichlorophenyl)piperazine hydrochloride.